Illumina Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom | Outperform |
8
|
$1.40k | $1.21k | 11.80% | 11 | $646.61B |
| MRK | Merck | Outperform |
2
|
$131.19 | $130.51 | 9.00% | 11 | $332.28B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | £165.99 | 34.64% | 16 | £187.73B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$595.30 | $591.94 | 4.15% | 1 | $227.24B |
| ROG | Roche Holding | Hold |
16
|
CHF237.10 | CHF307.83 | 14.93% | 9 | CHF191.28B |
| NOVN | Novartis | Hold |
10
|
CHF93.37 | CHF105.00 | 15.26% | 9 | CHF190.51B |
| DHR | Danaher | Outperform |
10
|
$265.80 | $260.33 | 2.49% | 4 | $196.87B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | $118.92 | 21.53% | 7 | $181.08B |
| AMGN | Amgen | Outperform |
4
|
$312.47 | $303.65 | 2.41% | 8 | $167.62B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
| GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.39B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | $58.15 | 22.64% | 10 | $89.25B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | $87.82 | 18.13% | 14 | $84.36B |
| A | Agilent Technologies | Outperform |
10
|
$154.23 | $138.82 | -2.09% | 10 | $45.20B |
| LONN | Lonza Group | Buy |
16
|
CHF529.20 | CHF516.89 | 13.38% | 8 | CHF38.16B |
| DSFIR | DSM-Firmenich | Outperform |
18
|
107.45€ | 114.60€ | 11.68% | 0 | 28.50€B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$210.59 | $241.28 | 14.92% | 9 | $17.75B |
| SY1 | Symrise | Outperform |
18
|
102.40€ | 106.97€ | 7.42% | 5 | 14.31€B |
| BIM | bioMérieux | Outperform |
18
|
95.90€ | 105.55€ | 19.92% | 1 | 11.73€B |
| TECH | Bio-Techne Corp | Buy |
16
|
$83.81 | $100.78 | 0.23% | 2 | $12.55B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.80k | Rp5.67k | 4.32% | 25 | Rp977.65B |
| NTRA | Natera | Buy |
7
|
$106.46 | $74.41 | 17.41% | 8 | $11.68B |
| 6869 | Sysmex | Outperform |
18
|
¥7.99k | ¥8.90k | 11.40% | 0 | ¥1.74T |
| EXAS | Exact Sciences | Buy |
8
|
$50.38 | $90.32 | 68.72% | 7 | $9.96B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$45.69 | $0.00 | 9.43% | 3 | $9.67B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.08 | £65.12 | 8.33% | 6 | £6.81B |
| BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$293.85 | $536.80 | 40.89% | 1 | $7.92B |
| WCH | Wacker Chemie | Outperform |
17
|
103.15€ | 145.36€ | 21.18% | 9 | 5.00€B |
| CLN | Clariant | Outperform |
18
|
CHF14.42 | CHF16.11 | 10.96% | 6 | CHF4.67B |
| BIOCON | Biocon | Hold |
14
|
Rp305.85 | Rp270.86 | -5.18% | 14 | Rp365.06B |
| TNE | Technology One | Hold |
16
|
$15.85 | $16.29 | 3.79% | 12 | $5.25B |
| ALRM | Alarm.com Holdings | Outperform |
16
|
$69.04 | $67.13 | 21.67% | 7 | $3.45B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$12.38 | HK$3.96 | -68.98% | 0 | HK$26.30B |
| QDEL | Quidel Corp | Hold |
16
|
$42.82 | $121.00 | 12.10% | 6 | $2.92B |
| AZTA | Azenta | Hold |
16
|
$50.87 | $58.50 | 12.05% | 5 | $2.87B |
| TWST | Twist Bioscience | Outperform |
4
|
$47.01 | $34.00 | -4.28% | 2 | $2.40B |
| GH | Guardant Health | Buy |
6
|
$25.36 | $43.00 | 51.81% | 2 | $2.37B |
| PENN | PENN Entertainment | Outperform |
13
|
$15.93 | $29.89 | 31.83% | 1 | $2.29B |
| 300676 | BGI Genomics | - |
17
|
¥41.30 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| NEO | NeoGenomics | Outperform |
8
|
$14.80 | $20.09 | 28.38% | 9 | $1.95B |
| MYGN | Myriad Genetics | Outperform |
6
|
$25.29 | $22.08 | -1.15% | 8 | $1.79B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| LAB | Standard BioTools | Buy |
11
|
$2.57 | $4.00 | 36.19% | 1 | $856.71M |
| 000710 | Berry Genomics Co.,Ltd | - |
10
|
¥7.23 | ¥56.76 | -100.00% | 0 | ¥5.09B |
| QTRX | Quanterix | Outperform |
11
|
$17.34 | $32.00 | 73.01% | 0 | $663.97M |
| FLGT | Fulgent Genetics | Hold |
16
|
$22.11 | $31.50 | 13.07% | 2 | $642.86M |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$3.61 | $8.67 | 52.35% | 2 | $515.79M |
| CEVI | CellaVision AB (publ) | Outperform |
16
|
kr235.00 | kr191.75 | 4.26% | 3 | kr5.38B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$2.02 | $12.67 | 73.27% | 4 | $468.43M |
| MACAY | Macay Holdings | - |
16
|
Php7.00 | Php0.00 | -100.00% | 0 | Php9.07B |
| GLAXO | GlaxoSmithKline Pakistan | - |
18
|
₨79.00 | ₨0.00 | -100.00% | 0 | ₨37.46B |
| PSNL | Personalis | Outperform |
6
|
$1.40 | $4.45 | 185.71% | 3 | $80.14M |
| IMMNOV | Immunovia AB (publ) | - |
0
|
kr1.94 | kr0.00 | -100.00% | 0 | kr747.75M |
| HEALTH | Nightingale Health Oyj | Underperform |
2
|
1.58€ | 1.10€ | 1.27% | 1 | 61.31€M |
| BNGO | Bionano Genomics | Outperform |
6
|
$1.14 | $12.33 | 426.32% | 2 | $65.69M |
| AGL | ANGLE | Buy |
8
|
£0.21 | £0.97 | 228.57% | 0 | £46.23M |
| TTOO | T2 Biosystems | Hold |
6
|
$5.64 | $8.68 | -46.81% | 0 | $31.92M |
| CNTG | Centogene N.V. | Outperform |
8
|
$0.37 | $1.37 | 272.97% | 0 | $23.96M |
| FRES | Fresh2 Group | - |
0
|
$0.39 | $0.00 | -100.00% | 0 | $20.50M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.88 | $5.00 | -100.00% | 1 | $19.07M |
| PRPO | Precipio | - |
0
|
$6.29 | $19.00 | -100.00% | 1 | $9.24M |
| NSTG | NanoString Technologies | - |
7
|
$0.12 | $5.02 | -100.00% | 4 | $6.98M |
| OPGN | OpGen |
2
|
$0.46 | $3.00 | -100.00% | 1 | $5.81M | |
| NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |
| ECX | Epigenomics | Outperform |
6
|
1.70€ | 52.65€ | 829.41% | 1 | 1.50€M |
| BIOC.Q | Biocept | Hold |
-16
|
$0.00 | $8.00 | 0.00% | 0 | $0.13M |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| HTGM.Q | HTG Molecular Diagnostics | - |
6
|
$0.00 | $6.00 | 0.00% | 1 | $0.00M |